Related Experiment Video
Updated: Aug 6, 2026

09:05
MicroRNA-based Regulation of Picornavirus Tropism
Published on: February 6, 2017
Host transcriptional corepressor TLE1 is commonly exploited by RNA viruses for replication
Xiaomeng Yang1, Haoran Sun2, Peng Luo3
1Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China.
Molecular Cell
|July 21, 2026
Summary
RNA viruses, including influenza A virus (IAV) and SARS-CoV-2, hijack host transcription factors like TLE1 and KLF4 via a conserved motif. This interaction aids viral replication and suppresses innate immunity, offering potential antiviral targets.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Viral genomes encode transcriptional regulators that manipulate host gene expression for replication.
- The intricate regulatory networks governing these interactions are not fully understood.
- Influenza A virus (IAV) serves as a model to investigate these mechanisms.
Purpose of the Study:
- To elucidate the role of viral transcriptional regulators in host gene modulation.
- To identify host factors exploited by viruses for replication and immune evasion.
- To explore potential therapeutic strategies targeting viral-host interactions.
Main Methods:
- Utilized IAV as a model system.
- Investigated the interaction between viral nucleoprotein (NP) and host transcriptional corepressor TLE1.
- Employed peptide inhibition (AH49A) to block NP-TLE1 interaction.
- Analyzed conserved motifs (basic helix-loop-helix-like) across different RNA viruses, including SARS-CoV-2.
- Performed loss-of-function substitutions in motif regions.
Main Results:
- IAV NP harnesses host TLE1 to boost viral polymerase activity and suppress innate immune responses.
- A conserved basic helix-loop-helix (bHLH)-like motif in NP mediates TLE1 recognition, recruiting KLF4 to suppress antiviral signaling.
- Peptide AH49A targeting the NP-TLE1 interaction demonstrated antiviral protection in vitro and in vivo.
- The NP-TLE1-KLF4 axis and bHLH-like motifs are conserved across various RNA viruses, including SARS-CoV-2.
- Mutations in the bHLH-like motif attenuated replication of both IAV and SARS-CoV-2.
Conclusions:
- RNA viruses exploit host transcriptional machinery components for replication.
- The NP-TLE1-KLF4 interaction pathway is a conserved mechanism for viral immune evasion and replication enhancement.
- Targeting viral-host transcriptional interactions, specifically the bHLH-like motif, presents a promising antiviral strategy.
More Related Videos
Related Concept Videos
Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
LTR Retrotransposons
LTR retrotransposons are class I transposable elements with long terminal repeats flanking an internal coding region. These elements are less abundant in mammals compared to other class I transposable elements. About 8 percent of human genomic DNA comprises LTR retrotransposons. Some of the common examples of LTR retrotransposons are Ty elements in yeast and Copia elements in Drosophila.
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

